Advertisement
Loading...

Regencell Bioscience Holdings Limited

RGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$28.58
$1.67(6.21%)
U.S. Market opens in 28h 26m

Regencell Bioscience Holdings Limited (RGC) Stock Overview

Explore Regencell Bioscience Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.1B
P/E Ratio-2021.15
EPS (TTM)$-0.01
ROE-2.32%
Fundamental Analysis

AI Price Forecasts

1 Month$38.44
3 Months$94.08
1 Year Target$47.95

RGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Regencell Bioscience Holdings Limited (RGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $47.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2021.15 and a market capitalization of 14.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.21%
5-Day Change
-7.98%
1-Month Change
-4.13%
3-Month Change
-8.46%
6-Month Change
126.83%
Year-to-Date (YTD) Change
36.10%
1-Year Change
170.13%
3-Year Change
4385.95%
5-Year Change
10243.08%
All-Time (Max) Change
10243.08%

Contact Information

https://www.regencellbioscience.com
852 2155 0823
First Commercial Building, Causeway Bay, NaN, KY1-1107

Company Facts

12 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions